MicroPort Medbot

What MicroPort Medbot does

MicroPort Medbot (Shanghai Microport Medbot (Group) Co., Ltd., HKEX: 02252.HK) is a Shanghai-headquartered surgical robotics company and subsidiary of MicroPort Scientific Corporation (00853.HK), founded as an internal MicroPort project in 2014 and spun out as a standalone entity in 2015. The company designs, manufactures, and commercializes a portfolio of surgical robotic systems targeting laparoscopic, orthopedic, vascular interventional, bronchoscopic, and percutaneous biopsy procedures, with regulatory approvals spanning NMPA (China), FDA (US), CE (EU), ANVISA (Brazil), TGA (Australia), MHLW (Japan), MHRA (UK), and CDSCO (India). Its core products include the Toumai multi-port and single-port laparoscopic robots, the SkyWalker orthopedic robot (TKA/THA), the DFVision 3D fluorescence endoscope, the R-One vascular intervention robot, the Mona Lisa prostate biopsy robot, and the Trans-bronchial Surgical Robot (Dudao); supporting infrastructure includes the Neuron remote surgery network covering 30+ hospitals across 30 cities in China. Technology differentiators include the world's first regulatory-approved full-spectrum remote surgical platform, 5G/LEO satellite-enabled telesurgery over distances exceeding 10,000 km, the Neuron AI model capable of 88% autonomous procedure completion in preclinical trials, and proprietary lightweight robotic arms with 97% domestic components.

Name

MicroPort Medbot

Legal name

Shanghai Microport Medbot (Group) Co., Ltd.

Website

https://medbotsurgical.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

501–1,000 employees

Short description

MicroPort Medbot (HKEX: 02252.HK) is a Shanghai-based surgical robotics subsidiary of MicroPort Scientific Corporation that develops and commercializes Toumai laparoscopic, SkyWalker orthopedic, R-One vascular, and bronchoscopic robotic systems across 60+ countries, serving tertiary hospitals and academic medical centers globally.

Ownership category

akta.pro rank

Product category

Surgical Robotics Systems

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Healthcare & Assistive Robotics (HDAAAIAC), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)

Keywords

• Surgical robotics systems
• Laparoscopic surgical robots
• Orthopedic surgical robots
• Remote surgery technology
• Medical imaging equipment

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Surgical Robot Systems Sales: Sale of surgical robotic systems including Toumai laparoscopic robot, SkyWalker orthopedic robot, and related equipment to hospitals and medical institutions globally. Revenue generated from system installations, with commercial deployment across 40+ countries
2. Consumables and Accessories: Ongoing sales of surgical instruments, replacement parts, and consumables for installed robotic systems. Products include specialized instruments for different surgical procedures
3. Training and Service Revenue: Revenue from training programs, installation services, maintenance contracts, and technical support associated with robotic systems. Includes partnership training centers like IRCAD collaboration

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

MicroPort Medbot develops and manufactures intelligent surgical robotics systems including multi-port and single-port laparoscopic robots (Toumai), orthopedic surgical robots (SkyWalker), vascular intervention robots (R-One), 3D electronic laparoscopes (DFVision), prostate biopsy robots (Mona Lisa), and trans-bronchial surgical robots. The company sells these robotic systems along with AI-enabled software, remote surgery platforms, consumables, and training services to hospitals and medical institutions worldwide.

Product overview

MicroPort MedBot is a comprehensive surgical robotics portfolio offering end-to-end intelligent surgical solutions across five major procedural categories: laparoscopic (Toumai®), orthopedic (SkyWalker®), vascular intervention (R-One®), transbronchial, and percutaneous procedures. The product family includes multi-port and single-port laparoscopic robots, 3D fluorescence imaging systems (DFVision®), orthopedic joint replacement robots, vascular intervention robots, prostate biopsy robots, and bronchoscopy robots. The portfolio is unified through shared AI-enabled automation capabilities (Neuron AI), remote surgery infrastructure (Toumai® Remote System), and a proprietary Neuron® telesurgery network spanning 30+ cities. Key differentiators include industry-leading remote surgery capability via 5G/satellite connectivity and autonomous surgical features. The company operates as a subsidiary of MicroPort Scientific Corporation (00853.HK) and is listed on Hong Kong Stock Exchange (02252.HK).

Differentiator

Problem solved

Functional benefit

Brands

• Toumai®: Multi-port laparoscopic surgical robot for urology, general surgery, thoracic, gynecological and pediatric surgeries
• SkyWalker™ / 鸿鹄®
• DFVision® / 蜻蜓眼®
• R-One®
• Mona Lisa / 慧鱼®

Products and services

• Toumai® Laparoscopic Surgical Robot (图迈®腔镜手术机器人) A fully China-independently-developed multi-port laparoscopic surgical robot with 3D visualization, intuitive master-slave teleoperation, and highly flexible instruments for urological, general, thoracic, gynecological and pediatric surgeries. Features industry-leading remote surgery capability via 5G, satellite, and broadband networks.
• SkyWalker® Orthopedic Surgical Robot (鸿鹄®骨科手术机器人) First and only Chinese surgical robot certified by NMPA, FDA, CE, ANVISA, TGA, and MHLW, designed for total knee arthroplasty (TKA) and total hip arthroplasty (THA) with AI-based preoperative planning, precise bone cutting, and reduced surgical errors to ±0.5°.
• DFVision® 3D Fluorescence Endoscope (蜻蜓眼®DFVision®三维电子腹腔内窥镜) Core imaging component of the Toumai® surgical robot featuring multimodal fluorescence with eight modes, using indocyanine green (ICG) contrast agent for real-time visualization of tissue function, blood perfusion, and tumor margins during surgery.
• R-One® Vascular Intervention Robot (R-One®血管介入手术机器人) Coronary and peripheral vascular intervention robot enabling precise remote catheter manipulation, reducing X-ray exposure for medical staff while maintaining accuracy in complex vascular procedures.
• Mona Lisa Prostate Biopsy Robot (Mona Lisa前列腺穿刺机器人定位系统) Multi-disciplinary robot-assisted transperineal prostate biopsy system combining robot technology for minimally invasive, accurate, stable, and safe prostate biopsy procedures under transrectal ultrasound guidance.
• Trans-bronchial Surgical Robot (经支气管手术机器人) Bronchoscopy robot designed to reach targeted lung lesions through natural airways using flexible robotics with autopilot navigation capability.
• ANT (Automated Needle Targeting Robotics Systems) Percutaneous biopsy robot that analyzes X-ray or CT images, generates models, and automatically calculates puncture paths through AI algorithms for accurate biopsies in lung and kidney procedures.
• Toumai® Single-Port Laparoscopic Surgical Robot Single-incision laparoscopic surgical robot with dual C-arm architecture and high-flexibility snake-like instruments enabling precision in tight spaces and wide-range multi-quadrant operations.

Quantifiable outcome

• Surgery time reduced by approximately 50%
• +6 more outcomes

Named customers17 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature10 records

Partnerships

Six partnerships are on record, tiered flagship and core.

• IRCAD (Institute of Research against Digestive Cancer)flagshipStrategic or Co-development Partner · 16 July 2025Jointly inaugurated Toumai Robotics Training Center in Strasbourg, France at SRS2025 conference. IRCAD founder Prof. Jacques Marescaux (pioneer of remote surgery's 2001 Lindbergh Operation) participated, symbolizing fusion of historic and future remote surgery innovation. Center serves as platform for global training, academic collaboration, and clinical research.
• Shanghai Ninth People's Hospital, Shanghai Jiao Tong UniversitycoreStrategic or Co-development PartnerFive-year industry-university-research partnership for SkyWalker orthopedic robot development, producing first domestically developed surgical robot with certifications across major markets.
• ORSI (Belgium)coreStrategic or Co-development PartnerEuropean training and academic partnership supporting robotic surgery adoption in Europe.
• Robocath (France)coreTechnology or IntegrationStrategic partnership established in 2020 for R-One vascular intervention robot development and中国市场 distribution.
• National Healthcare Security Administration (China)flagshipOthersGovernment body that issued nationwide pricing guidelines for surgical robot auxiliary operations, establishing standardized national pricing tiers for remote surgery assistance fees, directly benefiting MicroPort MedBot's commercialization efforts.
• Thailand Ministry of HealthcoreGTM or Marketing PartnerNational collaboration driving adoption of Toumai through designated training center at Rajavithi Hospital.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Stryker: Maker of the Mako robotic system for orthopedic joint replacement (TKA/THA). Direct peer to SkyWalker in robotic-assisted knee and hip arthroplasty, with established global installed base and FDA/NICE-cleared systems competing for the same hospital budgets.
• Intuitive Surgical: Global leader in surgical robotics with the da Vinci platform—the dominant multi-port laparoscopic surgical robot. Directly comparable to Toumai in soft-tissue surgical applications with thousands of installed systems worldwide and the gold-standard incumbent that MedBot competes against globally.
• Medtronic: Developer of the Hugo robotic-assisted surgery system for soft-tissue procedures. Major medtech incumbent entering surgical robotics as a direct competitor to Toumai in laparoscopic applications, leveraging its global hospital sales infrastructure.
• Johnson & Johnson (Ethicon): Developer of the Ottava robotic surgical platform (in development/launch phase). Major medtech incumbent competing in soft-tissue surgical robotics with deep R&D resources and hospital relationships overlapping MedBot's target market.

Direct peers

• Robocath: French developer of the R-One vascular intervention robot—actually a MicroPort partner for the China market. Direct peer in robotic-assisted percutaneous coronary intervention, addressing the same clinical use case as MedBot's R-One platform.
• THINK Surgical: Developer of the TSolution One robotic system for orthopedic joint replacement. Comparable to SkyWalker in TKA/THA applications with established FDA clearance and similar target hospital segment of orthopedic specialty centers.
• Smith+Nephew: Maker of the CORI handheld robotic-assisted orthopedic surgery system. Direct competitor to SkyWalker in joint replacement robotics, targeting similar ambulatory surgery centers and orthopedic specialty hospitals.
• TINAVI Medical Technologies: Chinese surgical robotics competitor and direct peer in both orthopedic and laparoscopic segments. TINAVI's Tianji robot competes with SkyWalker in orthopedics domestically, making it the closest head-to-head competitor in the Chinese market.

Emerging players

• Vicarious Surgical: Emerging developer of a single-port robotic surgical system with virtual reality interface. Comparable to MedBot's newly approved Toumai Single-Port system in addressing the single-incision surgical robotics category with similar miniaturization ambitions.
• Edge Medical Robotics: Chinese surgical robotics startup developing laparoscopic and orthopedic robotic systems. Emerging direct competitor in the same Chinese market segment, pursuing similar minimally invasive surgical robotics applications as MedBot.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks7 records

Key highlights8 records

Customer concentration

• Xtwitter.com/MedBotSurgical
• Facebookfacebook.com/profile.php?id=100088839135531
• LinkedInlinkedin.com/company/microport-medbot

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroPort Medbot